根据一份提交给美国证券交易委员会（SEC）的文件，芯科实验室与德州仪器拟议合并所涉及的《哈特-斯科特-罗迪诺反垄断改进法案》规定的等待期，已于2026年5月22日正式届满。
这一关键时间节点的达成，标志着该交易在反垄断审查方面迈出了重要一步。HSR法案等待期的届满，意味着美国联邦贸易委员会和司法部在法定审查期内未对交易提出异议或要求提供更多信息，从而为合并的继续进行扫清了一道主要监管障碍。
不过，这并不意味着交易已最终完成。合并双方仍需满足其他惯常的交割条件，并获得所有必要的监管批准。市场参与者正密切关注交易的后续进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.